PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of medicineHomeSearchSubmit a ManuscriptMedicine
 
Medicine (Baltimore). 2017 July; 96(29): e7644.
Published online 2017 July 21. doi:  10.1097/MD.0000000000007644
PMCID: PMC5521951

Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum

In the article, “Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report”,[1] which appeared in Volume 96, Issue 21 of Medicine, “Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China” should have appeared as “Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.”

Reference

[1] Liang J-Y, Tong F, Gu F-F. Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report. Medicine. 2017. 96:e6985. [PMC free article] [PubMed]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health